Apr 27, 2021
MANISTIQUE Nicolet National Bank, headquartered in Green Bay, Wis., will expand its reach into Michigan with the acquisition of Mackinac Financial Corp., parent company of mBank, for a mix of cash and stock valued at $248 million.
“The acquisition of mBank is an important step in Nicolet’s planned growth,” said Mike Daniels, president and CEO of Nicolet National Bank. “This deal is not about expanded geographies but rather about the characteristics of the communities we will serve. Together we will combine two organizations that understand the positive impact that a strong community bank can make. We look forward to becoming an integral part of the Upper Peninsula and northern Michigan.”
Mackinac Financial (mBank) Bought by Wisconsin s Nicolet dbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dbusiness.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
GREEN BAY, Wis. and MANISTIQUE, Mich., April 12, 2021 /PRNewswire/ Nicolet Bankshares, Inc. (NASDAQ: NCBS) ( Nicolet ) and Mackinac Financial Corporation (NASDAQ: MFNC) ( Mackinac ) today jointly announced the execution of a definitive merger agreement, pursuant to which Nicolet will acquire Mackinac and its wholly-owned banking subsidiary, mBank.
Mackinac Financial
Based on the financial results as of December 31, 2020, the combined company will have pro forma total assets of $6.1 billion, deposits of $5.2 billion and loans of $3.9 billion, and Mackinac would represent approximately 25% of the combined company s year-end assets.
Mike Daniels, President and CEO of Nicolet National Bank said, The acquisition of mBank is an important step in Nicolet s planned growth. This deal is not about expanded geographies but rather about the characteristics of the communities we will serve. Together, we will combine two organizations that
The Substance Use Advance Directive (SUAD) has the potential to greatly improve the current state of treatment for life-threatening comorbid conditions in SUD patients through reducing AMA discharges, writes Paul Tobias, MD, JD, MBA, of Ohio Health, Columbus.
But in an accompanying commentary, Kelly K. Dineen, JD, PhD, of Creighton University, Omaha, Neb., cites obvious practical and ethical challenges to the SUAD concept, including the lack of any legal basis for overruling patients if they later decide to refuse treatment: As long as a patient has capacity, they almost always have the final say in consenting to or refusing care.